EA200400042A1 - Стереоселективный способ получения нуклеозидных аналогов - Google Patents

Стереоселективный способ получения нуклеозидных аналогов

Info

Publication number
EA200400042A1
EA200400042A1 EA200400042A EA200400042A EA200400042A1 EA 200400042 A1 EA200400042 A1 EA 200400042A1 EA 200400042 A EA200400042 A EA 200400042A EA 200400042 A EA200400042 A EA 200400042A EA 200400042 A1 EA200400042 A1 EA 200400042A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
nucleoside analogs
stereoelective
obtaining
pyrimidine base
Prior art date
Application number
EA200400042A
Other languages
English (en)
Other versions
EA006372B1 (ru
Inventor
Цинг Ю
Original Assignee
Шаэр Биокем, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шаэр Биокем, Инк. filed Critical Шаэр Биокем, Инк.
Publication of EA200400042A1 publication Critical patent/EA200400042A1/ru
Publication of EA006372B1 publication Critical patent/EA006372B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Изобретение относится к способу получения преимущественно цис-нуклеозидов или нуклеозидных аналогов и производных формулы (A), где Rявляется пиримидиновым основанием или его фармацевтически приемлемым производным и Q является кислородом, углеродом или серой, включающий стадию конденсации пиримидинового основания с соединением формулы (B), представленным в настоящем изобретении, в подходящем для конденсации растворителе, в присутствии каталитического количества элемента или комбинации элементов группы IB или IIB Периодической таблицы, третичного амина и кислоты Льюиса с получением промежуточного соединения формулы (D), которое подвергается снятию защиты на последующей стадии получения продукта формулы (A).Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400042A 2001-06-15 2002-06-14 Стереоселективный способ получения нуклеозидных аналогов EA006372B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29807901P 2001-06-15 2001-06-15
PCT/CA2002/000899 WO2002102796A1 (en) 2001-06-15 2002-06-14 Stereoselective method for the preparation of nucleoside analogues

Publications (2)

Publication Number Publication Date
EA200400042A1 true EA200400042A1 (ru) 2004-06-24
EA006372B1 EA006372B1 (ru) 2005-12-29

Family

ID=23148927

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400042A EA006372B1 (ru) 2001-06-15 2002-06-14 Стереоселективный способ получения нуклеозидных аналогов

Country Status (29)

Country Link
US (2) US7109334B2 (ru)
EP (2) EP1406896B8 (ru)
JP (1) JP4542776B2 (ru)
KR (1) KR100832617B1 (ru)
CN (1) CN1297553C (ru)
AP (1) AP1559A (ru)
AT (2) ATE370945T1 (ru)
AU (2) AU2002344862C1 (ru)
BR (2) BR0210444A (ru)
CA (1) CA2449338C (ru)
CO (1) CO5550497A2 (ru)
CY (1) CY1107805T1 (ru)
DE (2) DE60222031T2 (ru)
DK (2) DK1632490T3 (ru)
EA (1) EA006372B1 (ru)
ES (2) ES2254695T3 (ru)
HK (1) HK1070652A1 (ru)
HR (1) HRP20031021B1 (ru)
IL (2) IL159139A0 (ru)
MX (1) MXPA03011627A (ru)
NO (1) NO326135B1 (ru)
NZ (1) NZ529906A (ru)
OA (1) OA12628A (ru)
PL (2) PL215267B1 (ru)
PT (1) PT1632490E (ru)
RS (1) RS50868B (ru)
SI (2) SI1632490T1 (ru)
WO (1) WO2002102796A1 (ru)
ZA (1) ZA200309307B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501514B1 (en) 2003-10-15 2009-03-10 Shire Biochem, Inc. Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
JP4653966B2 (ja) * 2004-04-19 2011-03-16 ダイセル化学工業株式会社 2−ベンゾイルオキシアセトアルデヒド誘導体の製造法
IN2015DN02599A (ru) * 2007-09-28 2015-09-18 Avexa Ltd
US20130165350A1 (en) * 2011-12-22 2013-06-27 Affymetrix, Inc. Surface linkers for array synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840001591A (ko) 1981-09-29 1984-05-07 구라바야시 이꾸시로 당케탈류의 제조방법
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
ES2091948T3 (es) * 1990-11-13 1996-11-16 Iaf Biochem Int 1,3-oxatiolanos sustituidos con propiedades antiviricas.
US5532349A (en) 1993-07-20 1996-07-02 Mitsui Toatsu Chemicals, Inc. Process for producing 1-(2'-deoxy-β-D-erythro-pentofuranosyl)-5-trifluoromethyluracil derivatives
EP1104415B1 (en) 1998-08-12 2004-11-10 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides

Also Published As

Publication number Publication date
RS50868B (sr) 2010-08-31
ATE313542T1 (de) 2006-01-15
US7109334B2 (en) 2006-09-19
US20030135048A1 (en) 2003-07-17
AP1559A (en) 2006-01-24
IL159139A0 (en) 2004-06-01
HRP20031021A2 (en) 2004-06-30
HK1070652A1 (en) 2005-06-24
CY1107805T1 (el) 2013-06-19
DE60222031D1 (de) 2007-10-04
EP1632490A1 (en) 2006-03-08
US7230100B2 (en) 2007-06-12
DE60222031T2 (de) 2008-05-21
DK1406896T3 (da) 2006-05-08
PL366907A1 (en) 2005-02-07
YU97503A (sh) 2006-05-25
ATE370945T1 (de) 2007-09-15
SI1406896T1 (sl) 2006-04-30
DE60208202D1 (de) 2006-01-26
KR20040017233A (ko) 2004-02-26
NO326135B1 (no) 2008-10-06
CN1543463A (zh) 2004-11-03
AU2002344862B2 (en) 2008-05-01
IL159139A (en) 2010-04-15
HRP20031021B1 (en) 2007-09-30
SI1632490T1 (sl) 2008-02-29
AU2002344862C1 (en) 2009-02-19
CN1297553C (zh) 2007-01-31
KR100832617B1 (ko) 2008-05-27
EP1406896B8 (en) 2006-11-15
PL401835A1 (pl) 2013-02-18
DE60208202T2 (de) 2006-08-17
OA12628A (en) 2006-06-13
ES2254695T3 (es) 2006-06-16
AU2008203443B2 (en) 2011-06-16
ZA200309307B (en) 2005-02-23
DK1632490T3 (da) 2008-01-28
WO2002102796A8 (en) 2003-09-18
PL218777B1 (pl) 2015-01-30
CO5550497A2 (es) 2005-08-31
EP1406896A1 (en) 2004-04-14
EA006372B1 (ru) 2005-12-29
BR0210444A (pt) 2004-08-17
JP2004535428A (ja) 2004-11-25
MXPA03011627A (es) 2005-03-07
AU2008203443A1 (en) 2008-08-21
NZ529906A (en) 2006-03-31
ES2293445T3 (es) 2008-03-16
CA2449338A1 (en) 2002-12-27
WO2002102796A1 (en) 2002-12-27
BRPI0210444B1 (pt) 2017-06-20
US20060183899A1 (en) 2006-08-17
EP1632490B1 (en) 2007-08-22
NO20035556D0 (no) 2003-12-12
JP4542776B2 (ja) 2010-09-15
PT1632490E (pt) 2007-11-07
CA2449338C (en) 2012-02-07
PL215267B1 (pl) 2013-11-29
EP1406896B1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
WO2004046112A3 (en) 3-amino-piperidine derivatives and processes for their preparation
CY1111876T1 (el) Νεες πυρρολες με υπολiπiδaiμiκες και υποχοληστερολαιμικες δραστικοτητες, μεθοδος για την παρασκευη αυτων και φαρμακευτικες συνθεσεις που τις περιεχουν και η χρηση αυτων στην ιατρικη
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
EA199900278A1 (ru) Модифицированные аминокислоты, содержащие эти соединения лекарственные средства и способ их получения
IS6859A (is) Kristölluð form atorvastatíns
DE10333239A1 (de) Verfahren zur Herstellung von gereinigten 1,3- substituierten Imidazoliumsalzen
WO2003084936A3 (en) Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
EA200400762A1 (ru) Новые соединения, их использование в медицине, способ их изготовления и содержащие их фармацевтические композиции
BR0307303A (pt) Processo para a fabricação de inibidores da hmg-coa redutase
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
EA200400042A1 (ru) Стереоселективный способ получения нуклеозидных аналогов
BR0213814A (pt) Processos para a fabricação de 3-hidroxi-n, 1,6-trialquil-4-oxo-1, 4-diidro piridino-2-carboxamida
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
EA200200939A1 (ru) Способ получения циталопрама
EA199800034A1 (ru) Способ получения n-монозамещенных и n,n'-дизамещенных асимметричных циклических мочевин
EA200200970A1 (ru) Способ получения циталопрама
EA200400323A1 (ru) Аралкилтетрагидропиридины, их получение и содержащие их фармацевтические композиции
EP1319656A4 (en) NEW METHOD FOR PRODUCING A CHINOLON CARBONIC ACID
EA200301224A1 (ru) Способ получения имипенема
EA200400739A1 (ru) Способ получения производных [1,4,5]оксадиазепина
EA200000924A2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
TC4A Change in name of a patent proprietor in a eurasian patent

Designated state(s): BY

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU